Jiangxi Synergy Pharmaceutical (300636.SZ): Fumaric acid fumarate raw material drug approved by CDE

Tonghe Pharmaceutical (300636.SZ) announced that the company recently found out through the "Registration Information Publicity" platform of the Drug Evaluation Center (CDE) of the National Medical Products Administration that the company's submission of the active pharmaceutical ingredient "levosulpiride fumarate" has been approved by the CDE. Levosulpiride fumarate is mainly used to treat gastroesophageal reflux disease.